ESMO 2014 Congress, Madrid

September 26, 2014 | Investor

Bavarian Nordic will attend the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid on September 26-30, 2014.

Bavarian Nordic will be present at the conference with an exhibit, where visitors can learn more about PROSTVAC and the PROSPECT clinical trial - a global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVAC® in men with asymptomatic and minimally symptomatic metastatic, castration-resistant prostate cancer .

Bavarian Nordic will also host a PROSTVAC update and reception for members of the investment community. Find more information via the link below.